Latest news
Why ImmunityBio (IBRX) Is Up 6.6% After ANKTIVA’s UAE Expansion and Mixed Q2 Results – And What's Next - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:34:48 GMTImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken In - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 03:42:41 GMTIBRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 19:14:04 GMTIBRX Stock In Spotlight: ImmunityBio To Unveil Fresh Anktiva And BCG Data Next Week - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 14:26:19 GMTImmunityBio Confirms Trial Strength For Anktiva In Bladder Cancer - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 08:38:18 GMTImmunityBio (IBRX) Stock Looks Rich On Sales But Strong On Returns - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 08:14:11 GMTThe Bull Case For ImmunityBio (IBRX) Could Change Following ANKTIVA’s Broad UAE Approval And Ongoing Losses - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 06:14:28 GMTImmunityBio (IBRX) group led by Soon-Shiong holds 64.8% stake - Stock TitanStock Titan · Thu, 06 Aug 2026 22:51:11 GMT